These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Abbott protease inhibitor lottery in January, CD4 under 50--registration now.
    Journal: AIDS Treat News; 1995 Dec 22; (no 237):3. PubMed ID: 11363074.
    Abstract:
    A lottery will be used to select 2,000 participants for Abbott Laboratories' worldwide expanded access program for the protease inhibitor, ritonavir (previously known as ABT-538). The lottery will begin in January 1996. Participants must be over the age of twelve and have CD4 counts less than fifty. Other medical qualifications are also necessary.
    [Abstract] [Full Text] [Related] [New Search]